Skip to content

A case registry study of anti-interferon-? autoantibody synthesis

A case registry study of anti-interferon-? autoantibody synthesis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112652
Enrollment
Unknown
Registered
2025-11-18
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-interferon-? autoantibody syndrome

Interventions

Observation group (Patients with clinically confirmed anti-interferon-? autoantibody syndrome):None

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. Patients diagnosed with anti-interferon-? autoantibody syndrome; (1)The diagnosis of Anti-interferon-? Autoantibody syndrome is based on the increased titer of anti-interferon-? autoantibody (AIGA) and positive neutralization test (BLI, flow cytometry, Elisa). 3. Patients complicated with opportunistic pathogens such as Talaromyces marneffei and non-tuberculous mycobacteria, and with prolonged disease course and disseminated infection; 4. Written informed consent was obtained before the study.

Exclusion criteria

Exclusion criteria: 1. Patients with other possible congenital or secondary immunodeficiency; 2. Not fit to participate in the study according to the investigator's judgment; 3. Suspected or real history of alcohol or drug abuse; 4. Those who did not sign the informed consent; 5. Participants deemed unsuitable by other investigators.

Design outcomes

Primary

MeasureTime frame
Prevalence rate;Level of geographical distribution;Common risk factors;Clinical Features;

Secondary

MeasureTime frame
The titer of AIGA;Clinical picture;Imaging findings;Changes in laboratory tests;

Countries

China

Contacts

Public ContactYe Feng

The First Affiliated Hospital of Guangzhou Medical University

yefeng@gird.cn+86 20 2427 7473

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026